CDKN2A and head and neck squamous cell carcinoma: In addition, hypermethylation of cyclin-dependent kinase inhibitor 2A (CDKN2a), a gene coding for tumor-suppressor genes p14ARF and p16INK4a, is involved in tumorigenesis of HNSCC and has also been investigated as a prognostic marker for this entity.